Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease

NCT05604183 is registered in ClinicalTrials.gov with Mantis Photonics AB as lead sponsor.

NCT NCT05604183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease
Lead sponsor
Mantis Photonics AB
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2022
Completion date
December 29, 2023
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, early onset, cognitive decline, cognitive impairment